Vnitr Lek 2009, 55(5):529

Dopisy redakci

Tomáš Doležal

Received: April 26, 2009; Published: May 1, 2009  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Doležal T. Dopisy redakci. Vnitr Lek. 2009;55(5):529.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Bartelds GM, Wijbrandts CA, Nurmohamed MT et al. Clinical Response to Adalimumab: Relationship to Anti-Adalimumab Antibodies and Serum Adalimumab Concentrations in Rheumatoid Arthritis. Ann Rheum Dis 2007; 66: 921-926. Go to original source... Go to PubMed...
    2. Moots RJ, Riel PV, Kekow J. Patterns of dose escalation and DMARD intensification in 739 patients with rheumatoid arthritis treated with anti-TNF agents: results from the DART study. British Society of Rheumatology annual meeting Liverpool. 2008. Ref Type: Conference Proceeding.
    3. Pavelka K, Jarosova K, Chroust K et al. Efficacy of switching between TNF inhibitors for the treatment of rheumatoid arthritis in the Czech national registry of biologicals ATTRA. Ann Rheum Dis 2008; 67 (Suppl II): 327.

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.